Table 1.
Characteristics of forty-four patients with localized prostate cancer
| Continuous | Log-transformed | |
|---|---|---|
| Age at treatment, median (IQR) | 61.0 (9.5) | |
| PSA pre-treatment (ng/ml), median (IQR) | 10.8 (13.8) | 3.4 (1.6) |
| Cancer percentage in tissue, median (IQR) | 90.0 (1.0) | |
| Gleason score (n) | ||
| 6 | 29 | |
| 7 | 10 | |
| 8–10 | 5 | |
| Cytokine tissue levels (expression/PBDG) | ||
| IL-7 | 6.0 (6.0) | 2.6 (1.3) |
| IL-7r | 3.4 × 107 (7.2 × 107) | 25.0 (2.5) |
| TGFβ1 | 44.5 (48.5) | 5.5 (1.4) |
Cytokine levels determined in prostate cancer tissues of the 44 prostate cancer patients studied. IL-7 interleukin 7, IL-7r interleukin 7 receptor, TGFβ1 tumor growth factor beta 1, PSA prostate-specific antigen, IQR interquartile range